All Articles

Fintech lender Lower is betting millions on a 2% grant to help buyers overcome the down payment hurdle. Is this a sustainable market disruption or a new risk?

Sharp Canada's new BP80C series isn't just a printer. It's an AI-driven, fortress-secure production hub designed to bring high-value print jobs back in-house.

AB InBev's new global campaign isn't just marketing. It's a strategic play backed by strong financials and data showing beer's resilient dominance.

AIR Global's plan to buy back a huge chunk of its shares raises key questions. Is it a bold move to boost value or a complex financial shuffle amid market headwinds?

Lifeward's pilot program with Ottobock Care isn't just a deal; it’s a strategic blueprint for scaling advanced medical tech in a new era of reimbursement.

As Ascentage Pharma preps its mid-year report, we look beyond the balance sheet at the strategic plays and clinical trials fueling its global oncology ambitions.

With a unique process for pristine graphene, HydroGraph heads to an elite investor conference, signaling a pivotal shift from R&D to industrial scale.

Expedition Therapeutics lands a huge Series B and starts a pivotal trial for a drug that could finally target the root cause of COPD for millions.

SmartRent’s surge to profitability and massive IoT booking growth signals a new era for rental housing, proving the digital backbone of our cities is here.

A new leaderboard on DefiLlama finally lets traders see how well market makers perform, adding a crucial new layer of data for judging a token's health.

Marex's strategic investment in Digital Prime Technologies isn't just a deal; it's a blueprint for bringing Wall Street's rigor to digital asset lending.

Phoenix Children's appoints Dr. Joshua Koch to a novel 'Hospital Based In Chief' role, a strategic move to manage growth and integrate complex patient care.

A new partnership uses smartphone AI to turn everyday movement into a vital sign, aiming to predict falls, manage chronic illness, and remake home healthcare.

Hult's five-year AMBA reaccreditation is more than an award; it's a validation of a model built for resilience, diversity, and real-world outcomes.

The largest wealth transfer in history meets a revolution in human longevity. A new breed of financial firm is betting your medical data is the key to it all.

With $20M in new capital, Ordway is doubling down on AI to automate the quote-to-cash mess. But can its profitable growth model redefine FinTech?

A new Atlassian Marketplace app from KMS Lighthouse targets 'context switching,' a quiet killer of enterprise productivity, by embedding governed knowledge in Jira.

As Maine's iconic angela adams transitions to new ownership, it offers a masterclass in how legacy brands can grow without losing their soul.

Fueled by SpaceX's blockbuster IPO and a stake in a new Jeff Bezos venture, Stack Capital’s Q2 gain offers a rare, liquid window into private tech.

iBase-t is moving beyond software sales, launching a Value Realization team to embed operational experts and quantitative ROI accountability on the shop floor.